Beyond Cholinesterase inhibitors: Exploring the Evidence for Other Modalities for Alzheimer's Disease Prevention and Treatment (CPE Only)

Beyond Cholinesterase inhibitors: Exploring the Evidence for Other Modalities for Alzheimer's Disease Prevention and Treatment (CPE Only) is organized by American Society of Consultant Pharmacists (ASCP).

Release Date: October 1st, 2021
Expiration Date: August 1, 2024

Activity Description and Purpose:
The treatment options for Alzheimer's disease are limited to four medications in two medications classes and nothing is approved for prevention. Caregivers, patients, and researchers are seeking options for prevention and treatment, but what is the evidence for modalities like light therapy, medical food, Ginkgo biloba, Vitamin E, and music therapy?

Learning Objectives:
At the conclusion of this application-based activity, participants should be able to:
• Classify the mechanism of actions for FDA approved medications for Alzheimer's Disease treatment.
• Compare FDA legal requirements of medical foods compared to prescription medications.
• Describe the research outcomes for light therapy for Alzheimer's Disease.
• Examine the evidence for music therapy for treatment of Alzheimer's disease.
• Examine the evidence for dietary supplements promoted for the prevention or treatment of Alzheimer's disease.